HLS Therapeutics Inc.

HLTRF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$17,456$21,952$20,723$21,179
Short-Term Investments$0$0$0$0
Receivables$7,525$10,694$11,194$11,511
Inventory$9,058$9,534$8,902$8,925
Other Curr. Assets$1,361$1,915$3,718$3,876
Total Curr. Assets$35,400$44,095$44,374$43,751
Property Plant & Equip (Net)$997$965$1,127$1,569
Goodwill$0$0$0$0
Intangibles$122,122$162,344$195,018$229,181
Long-Term Investments$0$5$668$713
Tax Assets$857$1,032$465$690
Other NC Assets$528$619$0$1
Total NC Assets$124,504$164,965$197,278$232,154
Other Assets$0$0$0$0
Total Assets$159,904$209,060$241,652$275,905
Liabilities
Payables$8,709$14,107$11,591$9,316
Short-Term Debt$5,284$5,156$13,584$12,606
Tax Payable$152$280$0$97
Deferred Revenue$0$0$4,128$4,849
Other Curr. Liab.$8,400$7,145-$2,241-$4,045
Total Curr. Liab.$22,545$26,688$31,190$27,672
LT Debt$61,166$82,465$83,761$84,960
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$4,074$442$566$653
Other NC Liab.$778$1,768$1,383$2,537
Total NC Liab.$66,018$84,675$85,144$87,497
Other Liabilities$0$0$0$0
Cap. Leases$882$884$1,010$1,432
Total Liabilities$88,563$111,363$116,334$115,169
Equity
Pref Stock$0$0$0$0
Common Stock$260,595$262,127$265,206$265,917
Retained Earnings-$194,180-$175,457-$148,449-$119,857
AOCI-$10,204-$2,838-$5,260$2,959
Other Equity$15,130$13,865$13,821$11,717
Total Equity$71,341$97,697$125,318$160,736
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$159,904$209,060$241,652$275,905
Net Debt$48,994$65,669$76,622$76,387